{"article_title": "First Biosimilar Poised For FDA Approval", "article_keywords": ["fda", "approval", "poised", "biosimilar"], "article_url": "http://www.forbes.com/sites/gracemarieturner/2015/02/13/first-biosimilar-poised-for-fda-approval/", "article_text": "", "article_metadata": {"prerender-status-code": "{{meta.code}}", "author": "Grace-Marie Turner", "og": {"site_name": "Forbes", "description": "Patients and payers have been anxiously awaiting approval of the first \u201cbiosimilar\u201d medicines in the United States, hoping the new biologics will lower the cost of these often lifesaving treatments. But early statements from makers of the first of these drugs likely to reach the market indicate that the company expects [...]", "title": "First Biosimilar Poised For FDA Approval", "url": "http://www.forbes.com/sites/gracemarieturner/2015/02/13/first-biosimilar-poised-for-fda-approval/", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "updated_time": "2015-02-13T13:37:34-05:00", "type": "article"}, "twitter": {"description": "Patients and payers have been anxiously awaiting approval of the first \u201cbiosimilar\u201d medicines in the United States, hoping the new biologics will lower the cost of these often lifesaving treatments. But early statements from makers of the first of these drugs likely to reach the market indicate that the company expects [...]", "creator": "@gracemarietweet", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "title": "First Biosimilar Poised For FDA Approval", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Healthcare  Fiscal,OpEd,Healthcare &amp; Fiscal,Op/Ed", "article": {"publisher": "https://www.facebook.com/forbes", "author": "http://www.facebook.com/GalenInstitute", "section_url": "http://www.forbes.com/opinion", "section": "Opinion", "modified": "2015-02-13", "published": "2015-02-13", "id": "blogAndPostId/blog/post/1939-1432"}, "news_keywords": "Healthcare  Fiscal,OpEd,Healthcare &amp; Fiscal,Op/Ed", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "description": "Patients and payers have been anxiously awaiting approval of the first \u201cbiosimilar\u201d medicines in the United States, hoping the new biologics will lower the cost of these often lifesaving treatments. But early statements from makers of the first of these drugs likely to reach the market indicate that the company expects [...]"}, "_id": "\"57477af46914bd0286fe07ce\"", "article_summary": ""}